Skip to main content
. 2016 Aug 20;7(38):61741–61754. doi: 10.18632/oncotarget.11437

Figure 2. High expression of ANRIL indicated a short overall survival and disease-free survival in NPC patients.

Figure 2

(A) The 5-year overall survival (OS) rate was 85.7% for the total study population. (B) The expression of ANRIL increased in advanced stages of NPC (C) Kaplan-Meier survival analysis of ANRIL expression for overall survival (D) Disease-free survival curves of patients with low and high ANRIL expression.